Health Catalyst, Inc. (NASDAQ:HCAT) Receives Consensus Recommendation of "Hold" from Analysts

Key Points

• Consensus "Hold" rating from 13 analysts (1 sell, 8 hold, 4 buy) with an average 1‑year target of $2.7955.
• Price targets have been cut recently by multiple brokers—e.g., Canaccord $5→$2, Wells Fargo $5→$1, Cantor Fitzgerald $4→$3—reflecting softer analyst expectations.
• Weak recent results and low valuation: Q1 EPS $0.08 missed the $0.10 estimate, revenue $74.7M, negative net margin of −57.2%, market cap ~$106.7M and shares trading around $1.45 (52‑week range $0.96–$5.06).

Shares of Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) have received a consensus rating of "Hold" from the thirteen ratings firms that are currently covering the stock, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and four have issued a buy recommendation on the company. The average 1 year target price among brokerages that have covered the stock in the last year is $2.7955.

HCAT has been the topic of a number of research reports. Canaccord Genuity Group decreased their target price on shares of Health Catalyst from $5.00 to $2.00 and set a "buy" rating on the stock in a research note on Friday, March 13th. Cantor Fitzgerald cut their price target on shares of Health Catalyst from $4.00 to $3.00 and set a "neutral" rating on the stock in a report on Friday, March 13th. Wells Fargo & Company reiterated an "equal weight" rating and set a $1.00 price target (down from $5.00) on shares of Health Catalyst in a report on Wednesday, March 18th. Raymond James Financial set a $3.00 price target on shares of Health Catalyst in a report on Friday, March 13th. Finally, Stifel Nicolaus cut their price target on shares of Health Catalyst from $3.75 to $2.00 and set a "hold" rating on the stock in a report on Friday, March 13th.

Health Catalyst Stock Performance

NASDAQ HCAT opened at $1.45 on Monday. The firm's fifty day moving average price is $1.38 and its two-hundred day moving average price is $2.11. The stock has a market cap of $106.71 million, a PE ratio of -0.57 and a beta of 1.63. Health Catalyst has a fifty-two week low of $0.96 and a fifty-two week high of $5.06. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.89 and a current ratio of 1.89.

Health Catalyst (NASDAQ:HCAT - Get Free Report) last posted its earnings results on Thursday, March 12th. The company reported $0.08 earnings per share for the quarter, missing analysts' consensus estimates of $0.10 by ($0.02). The company had revenue of $74.68 million for the quarter, compared to the consensus estimate of $73.99 million. Health Catalyst had a negative return on equity of 4.30% and a negative net margin of 57.20%. On average, equities analysts expect that Health Catalyst will post -0.28 EPS for the current fiscal year.

Hedge Funds Weigh In On Health Catalyst

Hedge funds have recently modified their holdings of the business. AMH Equity Ltd lifted its holdings in shares of Health Catalyst by 54.5% during the third quarter. AMH Equity Ltd now owns 660,000 shares of the company's stock worth $1,881,000 after purchasing an additional 232,851 shares during the period. First Light Asset Management LLC lifted its holdings in shares of Health Catalyst by 9.9% during the third quarter. First Light Asset Management LLC now owns 13,436,220 shares of the company's stock worth $38,293,000 after purchasing an additional 1,206,039 shares during the period. Focus Partners Wealth acquired a new position in shares of Health Catalyst during the first quarter worth $46,000. Hsbc Holdings PLC lifted its holdings in shares of Health Catalyst by 21.3% during the first quarter. Hsbc Holdings PLC now owns 98,868 shares of the company's stock worth $123,000 after purchasing an additional 17,332 shares during the period. Finally, 71 West Capital Partners acquired a new position in shares of Health Catalyst during the fourth quarter worth $383,000. Institutional investors and hedge funds own 85.00% of the company's stock.

About Health Catalyst

Health Catalyst NASDAQ: HCAT is a healthcare data and analytics technology company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in 2019 and has since focused on delivering a unified data platform that helps healthcare organizations aggregate and analyze clinical, financial and operational information.

The core of Health Catalyst's offering is the Data Operating System (DOS), a modular data management platform that integrates disparate data sources—from electronic health records to claims and patient-generated data—into a single analytics environment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.